Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Schizophrenia

Free Subscription Articles published in J Clin Psychopharmacol Retrieve available abstracts of 86 articles: HTML format

Single Articles

June 2008
1. KIM SW , Shin IS, Kim JM, Yang SJ, et al
   Amisulpride Improves Obsessive-Compulsive Symptoms in Schizophrenia Patients Taking Atypical Antipsychotics: An Open-Label Switch Study.
   J Clin Psychopharmacol. 2008;28:349-352.
   PubMed     Related articles   
   
   
   
2. GAU SS , Chung CH, Gau CS
   A Pharmacoeconomic Analysis of Atypical Antipsychotics and Haloperidol in First-Episode Schizophrenic Patients in Taiwan.
   J Clin Psychopharmacol. 2008;28:271-278.
   PubMed     Related articles    Abstract available
   
   
   
3. YUAN HN , Wang CY, Sze CW, Tong Y, et al
   A Randomized, Crossover Comparison of Herbal Medicine and Bromocriptine Against Risperidone-Induced Hyperprolactinemia in Patients With Schizophrenia.
   J Clin Psychopharmacol. 2008;28:264-370.
   PubMed     Related articles    Abstract available
   
   
   April 2008
4. VAN NIMWEGEN L , de Haan L, van Beveren N, Laan W, et al
   Obsessive-Compulsive Symptoms in a Randomized, Double-Blind Study With Olanzapine or Risperidone in Young Patients With Early Psychosis.
   J Clin Psychopharmacol. 2008;28:214-218.
   PubMed     Related articles    Abstract available
   
   
   
5. EMSLEY R , Medori R, Koen L, Oosthuizen PP, et al
   Long-Acting Injectable Risperidone in the Treatment of Subjects With Recent-Onset Psychosis: A Preliminary Study.
   J Clin Psychopharmacol. 2008;28:210-213.
   PubMed     Related articles    Abstract available
   
   
   
6. GAO K , Kemp DE, Ganocy SJ, Gajwani P, et al
   Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
   J Clin Psychopharmacol. 2008;28:203-9.
   PubMed     Related articles    Abstract available
   
   
   
7. KIM E , Park DW, Choi SH, Kim JJ, et al
   A Preliminary Investigation of alpha-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia.
   J Clin Psychopharmacol. 2008;28:138-46.
   PubMed     Related articles    Abstract available
   
   
   
8. POTKIN SG , Litman RE, Torres R, Wolfgang CD, et al
   Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
   J Clin Psychopharmacol. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
9. KANE JM , Lauriello J, Laska E, Di Marino M, et al
   Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
   J Clin Psychopharmacol. 2008;28.
   PubMed     Related articles    Abstract available
   
   
   
10. CUTLER AJ , Kalali AH, Weiden PJ, Hamilton J, et al
    Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    J Clin Psychopharmacol. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    
11. POTKIN SG
    New advances in the treatment of schizophrenia. Introduction.
    J Clin Psychopharmacol. 2008;28.
    PubMed     Related articles   
    
    
    
12. DEPP CA , Cain AE, Palmer BW, Moore DJ, et al
    Assessment of medication management ability in middle-aged and older adults with bipolar disorder.
    J Clin Psychopharmacol. 2008;28:225-9.
    PubMed     Related articles    Abstract available
    
    
    
13. BIRKENAES AB , Birkeland KI, Engh JA, Faerden A, et al
    Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions.
    J Clin Psychopharmacol. 2008;28:132-7.
    PubMed     Related articles    Abstract available
    
    
    
14. WEIDEN PJ , Cutler AJ, Polymeropoulos MH, Wolfgang CD, et al
    Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    J Clin Psychopharmacol. 2008;28.
    PubMed     Related articles    Abstract available
    
    
    February 2008
15. KONOPELSKA S , Quinkler M, Strasburger CJ, Ventz M, et al
    Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia-a case report with a review of the literature.
    J Clin Psychopharmacol. 2008;28:120-2.
    PubMed     Related articles   
    
    
    
16. PAVLOVIC ZM
    Augmentation of Clozapine's Antiagressive Properties With Lamotrigine in a Patient With Chronic Disorganized Schizophrenia.
    J Clin Psychopharmacol. 2008;28:119-20.
    PubMed     Related articles   
    
    
    
17. KILZIEH N , Todd-Stenberg JA, Kennedy A, Wood AE, et al
    Time to Discontinuation and Self-Discontinuation of Olanzapine and Risperidone in Patients With Schizophrenia in a Naturalistic Outpatient Setting.
    J Clin Psychopharmacol. 2008;28:74-77.
    PubMed     Related articles    Abstract available
    
    
    
18. CORTESE L , Caligiuri MP, Williams R, Schieldrop P, et al
    Reduction in Neuroleptic-Induced Movement Disorders After a Switch to Quetiapine in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2008;28:69-73.
    PubMed     Related articles    Abstract available
    
    
    
19. LANE HY , Liu YC, Huang CL, Chang YC, et al
    RGS4 Polymorphisms Predict Clinical Manifestations and Responses to Risperidone Treatment in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2008;28:64-68.
    PubMed     Related articles    Abstract available
    
    
    
20. FRIEDMAN JI , Carpenter D, Lu J, Fan J, et al
    A Pilot Study of Adjunctive Atomoxetine Treatment to Second-Generation Antipsychotics for Cognitive Impairment in Schizophrenia.
    J Clin Psychopharmacol. 2008;28:59-63.
    PubMed     Related articles    Abstract available
    
    
    
21. SADDICHHA S , Ameen S, Akhtar S
    Predictors of Antipsychotic-Induced Weight Gain in First-Episode Psychosis: Conclusions From a Randomized, Double-Blind, Controlled Prospective Study of Olanzapine, Risperidone, and Haloperidol.
    J Clin Psychopharmacol. 2008;28:27-31.
    PubMed     Related articles    Abstract available
    
    
    December 2007
22. LITVAN L , Alcoverro-Fortuny O
    Sibutramine and Psychosis.
    J Clin Psychopharmacol. 2007;27:726-727.
    PubMed     Related articles   
    
    
    
23. BERGEMANN N , Abu-Tair F, Strowitzki T
    Estrogen in the Treatment of Late-Onset Schizophrenia.
    J Clin Psychopharmacol. 2007;27:717-720.
    PubMed     Related articles   
    
    
    
24. KESHAVAN MS , Prasad KM, Montrose DM, Miewald JM, et al
    Sleep Quality and Architecture in Quetiapine, Risperidone, or Never-Treated Schizophrenia Patients.
    J Clin Psychopharmacol. 2007;27:703-705.
    PubMed     Related articles   
    
    
    
25. BYERLY M , Suppes T, Tran QV, Baker RA, et al
    Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum Disorders: Recent Developments and Current Perspectives.
    J Clin Psychopharmacol. 2007;27:639-661.
    PubMed     Related articles    Abstract available
    
    
    
26. GOFF DC , Keefe R, Citrome L, Davy K, et al
    Lamotrigine as Add-On Therapy in Schizophrenia: Results of 2 Placebo-Controlled Trials.
    J Clin Psychopharmacol. 2007;27:582-589.
    PubMed     Related articles    Abstract available
    
    
    
27. SURGULADZE SA , Chu EM, Evans A, Anilkumar AP, et al
    The Effect of Long-Acting Risperidone on Working Memory in Schizophrenia: A Functional Magnetic Resonance Imaging Study.
    J Clin Psychopharmacol. 2007;27:560-570.
    PubMed     Related articles    Abstract available
    
    
    
28. MATHEWSON KA , Lindenmayer JP
    Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    J Clin Psychopharmacol. 2007;27:714-5.
    PubMed     Related articles   
    
    
    
29. LIM M , Park DY, Kwon JS, Joo YH, et al
    Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics.
    J Clin Psychopharmacol. 2007;27:712-3.
    PubMed     Related articles   
    
    
    
30. BACHMANN CJ , Nicksch B, de Lange D, Theisen FM, et al
    Repeated creatine kinase elevation under treatment with quetiapine, clozapine, and aripiprazole in an adolescent.
    J Clin Psychopharmacol. 2007;27:710-1.
    PubMed     Related articles   
    
    
    
31. HE JL , Xiang YT, Li WB, Cai ZJ, et al
    Hemoperfusion in the treatment of acute clozapine intoxication in China.
    J Clin Psychopharmacol. 2007;27:667-71.
    PubMed     Related articles    Abstract available
    
    
    
32. KLUGE M , Schuld A, Himmerich H, Dalal M, et al
    Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.
    J Clin Psychopharmacol. 2007;27:662-6.
    PubMed     Related articles    Abstract available
    
    
    
33. CHAUDHRY IB , Husain N, Khan S, Badshah S, et al
    Amoxapine as an antipsychotic: comparative study versus haloperidol.
    J Clin Psychopharmacol. 2007;27:575-81.
    PubMed     Related articles    Abstract available
    
    
    
34. PELIZZA L , Melegari M
    Clozapine-induced microscopic colitis: a case report and review of the literature.
    J Clin Psychopharmacol. 2007;27:571-4.
    PubMed     Related articles    Abstract available
    
    
    October 2007
35. VARMA A
    Comments on "neurological soft signs in schizophrenic patients treated with conventional and atypical antipsychotics".
    J Clin Psychopharmacol. 2007;27:528.
    PubMed     Related articles   
    
    
    
36. HOUSTON JP , Adams DH, Kirkwood SC, Farmen M, et al
    Neuroreceptor gene polymorphisms and olanzapine depressive symptom response in schizophrenia.
    J Clin Psychopharmacol. 2007;27:520-3.
    PubMed     Related articles   
    
    
    
37. CHEN CH , Huang MC, Lu ML
    Aripiprazole Improves Metabolic Adversity in Olanzapine-Treated Schizophrenic Patients.
    J Clin Psychopharmacol. 2007;27:516-517.
    PubMed     Related articles   
    
    
    
38. DERVAUX A , Cazali J
    Clozapine and Amisulpride in Refractory Schizophrenia and Alcohol Dependence.
    J Clin Psychopharmacol. 2007;27:514-516.
    PubMed     Related articles   
    
    
    
39. DEUTSCHMAN DA , Deutschman DH
    High-Dose Ziprasidone in Treatment-Resistant Schizophrenia and Affective Spectrum Disorders: A Case Series.
    J Clin Psychopharmacol. 2007;27:513-514.
    PubMed     Related articles   
    
    
    
40. BERGEMANN N , Abu-Tair F, Kress KR, Parzer P, et al
    Increase in plasma concentration of amisulpride after addition of concomitant lithium.
    J Clin Psychopharmacol. 2007;27:546-9.
    PubMed     Related articles   
    
    
    
41. KANTROWITZ JT , Srihari VH, Tek C
    Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
    J Clin Psychopharmacol. 2007;27:525-6.
    PubMed     Related articles   
    
    
    
42. LAI YC , Chiou CC, Chen CH, Huang MC, et al
    Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
    J Clin Psychopharmacol. 2007;27:523-4.
    PubMed     Related articles   
    
    
    
43. CHUNG AK , Chua SE
    Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
    J Clin Psychopharmacol. 2007;27:517-9.
    PubMed     Related articles   
    
    
    
44. LEVINE SZ , Rabinowitz J
    Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale.
    J Clin Psychopharmacol. 2007;27:431-6.
    PubMed     Related articles    Abstract available
    
    
    August 2007
45. NAKAJIMA S , Uchida H, Suzuki T, Tomita M, et al
    An Open-Label Trial of Discontinuing Benzodiazepines in Patients With Chronic Schizophrenia.
    J Clin Psychopharmacol. 2007;27:401-403.
    PubMed     Related articles   
    
    
    
46. SHIM JC , Choe BM, Kim JG, Jae YM, et al
    Discontinuation of Risperidone, Olanzapine, and Haloperidol in First-Episode Psychosis.
    J Clin Psychopharmacol. 2007;27:400-401.
    PubMed     Related articles   
    
    
    
47. KAHN D , Bourgeois JA
    Acute pancreatitis and diabetic ketoacidosis in a schizophrenic patient taking olanzapine.
    J Clin Psychopharmacol. 2007;27:397-400.
    PubMed     Related articles   
    
    
    
48. LIU-SEIFERT H , Houston JP, Adams DH, Kinon BJ, et al
    Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia.
    J Clin Psychopharmacol. 2007;27:392-4.
    PubMed     Related articles   
    
    
    
49. EVINS AE , Cather C, Culhane MA, Birnbaum A, et al
    A 12-Week Double-Blind, Placebo-Controlled Study of Bupropion SR Added to High-Dose Dual Nicotine Replacement Therapy for Smoking Cessation or Reduction in Schizophrenia.
    J Clin Psychopharmacol. 2007;27:380-386.
    PubMed     Related articles    Abstract available
    
    
    
50. WU RR , Zhao JP, Zhai JG, Guo XF, et al
    Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
    J Clin Psychopharmacol. 2007;27:374-9.
    PubMed     Related articles    Abstract available
    
    
    
51. AGID O , Remington G, Kapur S, Arenovich T, et al
    Early Use of Clozapine for Poorly Responding First-Episode Psychosis.
    J Clin Psychopharmacol. 2007;27:369-373.
    PubMed     Related articles    Abstract available
    
    
    
52. MULDER H , Franke B, Beek van der AA, Arends J, et al
    The Association Between HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2007;27:338-343.
    PubMed     Related articles    Abstract available
    
    
    
53. DOSSENBACH M , Treuer T, Kryzhanovskaya L, Saylan M, et al
    Olanzapine Versus Chlorpromazine in the Treatment of Schizophrenia: A Pooled Analysis of Four 6-Week, Randomized, Open-Label Studies in the Middle East and North Africa.
    J Clin Psychopharmacol. 2007;27:329-337.
    PubMed     Related articles    Abstract available
    
    
    
54. EDLINGER M , Ebenbichler C, Rettenbacher M, Fleischhacker WW, et al
    Treatment of antipsychotic-associated hyperglycemia with pioglitazone: a case series.
    J Clin Psychopharmacol. 2007;27:403-4.
    PubMed     Related articles   
    
    
    
55. THINN SS , Liew E, May AL, Chua HC, et al
    Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic.
    J Clin Psychopharmacol. 2007;27:394-5.
    PubMed     Related articles   
    
    
    
56. KIM SH , Ivanova O, Abbasi FA, Lamendola CA, et al
    Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: a pilot study.
    J Clin Psychopharmacol. 2007;27:365-8.
    PubMed     Related articles    Abstract available
    
    
    June 2007
57. AGABIO R , Marras P, Addolorato G, Carpiniello B, et al
    Baclofen Suppresses Alcohol Intake and Craving for Alcohol in a Schizophrenic Alcohol-Dependent Patient: A Case Report.
    J Clin Psychopharmacol. 2007;27:319-320.
    PubMed     Related articles   
    
    
    
58. ROSENBOHM A , Bux CJ, Connemann BJ
    Psychosis with sibutramine.
    J Clin Psychopharmacol. 2007;27:315-7.
    PubMed     Related articles   
    
    
    
59. BAI YM , Chen TT, Lin WK, Chang WH, et al
    Pharmacokinetics Study for Hyperprolactinemia Among Schizophrenics Switched From Risperidone to Risperidone Long-Acting Injection.
    J Clin Psychopharmacol. 2007;27:306-308.
    PubMed     Related articles   
    
    
    
60. BEASLEY CM JR , Stauffer VL, Liu-Seifert H, Taylor CC, et al
    All-Cause Treatment Discontinuation in Schizophrenia During Treatment With Olanzapine Relative to Other Antipsychotics: An Integrated Analysis.
    J Clin Psychopharmacol. 2007;27:252-258.
    PubMed     Related articles    Abstract available
    
    
    
61. ZHANG XY , Tan YL, Zhou DF, Haile CN, et al
    Association of Clozapine-Induced Weight Gain With a Polymorphism in the Leptin Promoter Region in Patients With Chronic Schizophrenia in a Chinese Population.
    J Clin Psychopharmacol. 2007;27:246-251.
    PubMed     Related articles    Abstract available
    
    
    
62. HELLAND A , Spigset O
    Low serum concentrations of reboxetine in 2 patients treated with CYP3A4 inducers.
    J Clin Psychopharmacol. 2007;27:308-10.
    PubMed     Related articles   
    
    
    
63. CASADEMONT J , Garrabou G, Miro O, Lopez S, et al
    Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    J Clin Psychopharmacol. 2007;27:284-8.
    PubMed     Related articles    Abstract available
    
    
    
64. CITROME L , Macher JP, Salazar DE, Mallikaarjun S, et al
    Pharmacokinetics of aripiprazole and concomitant carbamazepine.
    J Clin Psychopharmacol. 2007;27:279-83.
    PubMed     Related articles    Abstract available
    
    
    April 2007
65. BABBAR J
    Smoking cessation in schizophrenia.
    J Clin Psychopharmacol. 2007;27:239-40.
    PubMed     Related articles   
    
    
    
66. PATON C , Whittington C, Barnes TR
    Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis.
    J Clin Psychopharmacol. 2007;27:198-204.
    PubMed     Related articles    Abstract available
    
    
    
67. PERITOGIANNIS V , Goulia P, Pappas D, Hyphantis T, et al
    Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
    J Clin Psychopharmacol. 2007;27:235-7.
    PubMed     Related articles   
    
    
    
68. SAHOO S , Ameen S
    Acute nocturnal akathisia induced by clozapine.
    J Clin Psychopharmacol. 2007;27:205.
    PubMed     Related articles   
    
    
    
69. PETRAKIS I , Ralevski E, Nich C, Levinson C, et al
    Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    J Clin Psychopharmacol. 2007;27:160-5.
    PubMed     Related articles    Abstract available
    
    
    February 2007
70. MARCHAND J , Grignon S
    A Case-Control Study of Patients With Resistant Schizophrenia After Clozapine Discontinuation.
    J Clin Psychopharmacol. 2007;27:90-91.
    PubMed     Related articles   
    
    
    
71. REIST C , Mintz J, Albers LJ, Jamal MM, et al
    Second-Generation Antipsychotic Exposure and Metabolic-Related Disorders in Patients With Schizophrenia: An Observational Pharmacoepidemiology Study From 1988 to 2002.
    J Clin Psychopharmacol. 2007;27:46-51.
    PubMed     Related articles    Abstract available
    
    
    
72. KRAMER M , Simpson G, Maciulis V, Kushner S, et al
    Paliperidone Extended-Release Tablets for Prevention of Symptom Recurrence in Patients With Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.
    J Clin Psychopharmacol. 2007;27:6-14.
    PubMed     Related articles    Abstract available
    
    
    
73. OPGEN-RHEIN C , Neuhaus AH, Dettling M
    Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
    J Clin Psychopharmacol. 2007;27:92-3.
    PubMed     Related articles   
    
    
    December 2006
74. ABU-TAIR F , Kopitz J, Bergemann N
    Clozapine Augmented With Aripiprazole in 5 Patients With Schizophrenia.
    J Clin Psychopharmacol. 2006;26:669-671.
    PubMed     Related articles   
    
    
    
75. SMELSON DA , Tunis SL, Nyhuis AW, Faries DE, et al
    Antipsychotic Treatment Discontinuation Among Individuals With Schizophrenia and Co-occurring Substance Use.
    J Clin Psychopharmacol. 2006;26:666-667.
    PubMed     Related articles   
    
    
    
76. KINON BJ , Liu-Seifert H, Adams DH, Citrome L, et al
    Differential Rates of Treatment Discontinuation in Clinical Trials as a Measure of Treatment Effectiveness for Olanzapine and Comparator Atypical Antipsychotics for Schizophrenia.
    J Clin Psychopharmacol. 2006;26:632-637.
    PubMed     Related articles    Abstract available
    
    
    
77. HOWES OD , Smith S, Gaughran FP, Amiel SA, et al
    The Relationship Between Prolactin Levels and Glucose Homeostasis in Antipsychotic-treated Schizophrenic Patients.
    J Clin Psychopharmacol. 2006;26:629-631.
    PubMed     Related articles    Abstract available
    
    
    
78. HARO JM , Novick D, Suarez D, Alonso J, et al
    Remission and Relapse in the Outpatient Care of Schizophrenia: Three-year Results From the Schizophrenia Outpatient Health Outcomes Study.
    J Clin Psychopharmacol. 2006;26:571-578.
    PubMed     Related articles    Abstract available
    
    
    
79. CHANG YC , Lane HY, Yang KH, Huang CL, et al
    Optimizing Early Prediction for Antipsychotic Response in Schizophrenia.
    J Clin Psychopharmacol. 2006;26:554-559.
    PubMed     Related articles    Abstract available
    
    
    
80. LIN GL , Chiu CH, Lin SK
    Quetiapine-induced erythema multiforme minor: a case report.
    J Clin Psychopharmacol. 2006;26:668-9.
    PubMed     Related articles   
    
    
    
81. PADALA PR , Sadiq HJ, Padala KP
    Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.
    J Clin Psychopharmacol. 2006;26:667-8.
    PubMed     Related articles   
    
    
    October 2006
82. KANG SG , Lee HJ, Lee MS, Kim L, et al
    Atypical neuroleptic malignant syndrome associated with aripiprazole.
    J Clin Psychopharmacol. 2006;26:534.
    PubMed     Related articles   
    
    
    
83. RETTENBACHER MA , Baumgartner S, Eder-Ischia U, Edlinger M, et al
    Association between antipsychotic-induced elevation of liver enzymes and weight gain: a prospective study.
    J Clin Psychopharmacol. 2006;26:500-3.
    PubMed     Related articles    Abstract available
    
    
    April 2006
84. LANE HY , Liu YC, Huang CL, Chang YC, et al
    Risperidone-related weight gain: genetic and nongenetic predictors.
    J Clin Psychopharmacol. 2006;26:128-34.
    PubMed     Related articles    Abstract available
    
    
    February 2006
85. GLICK ID , Duggal V, Hodulik C
    Aripiprazole as a dopamine partial agonist: positive and negative effects.
    J Clin Psychopharmacol. 2006;26:101-3.
    PubMed     Related articles   
    
    
    
86. GIBSON CA , Stewart JT
    Treatment of psychogenic polydipsia with pindolol.
    J Clin Psychopharmacol. 2006;26:99-100.
    PubMed     Related articles   
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: